Name | Fletikumab |
---|
Description | Fletikumab (NNC0109-0012) is a monoclonal antibody targeting to IL-20. Fletikumab can be used for inflammation research, such as rheumatoid arthritis[1]. |
---|---|
Related Catalog | |
Target |
IL-20[1] |
In Vitro | Fletikumab blocks IL-20 binding IL-20 receptor, acts potential function of inflammation inhibition[1]. IL-20 is a member of IL-10 family, which includes IL-10, IL-19, IL-22, IL-24, IL-26, IL-28, and IL-29. IL-20 acts on renal cells and contributes to inflammation, fibrosis, and apoptosis through its receptors IL-20R1, IL-20R2, and IL-22R1[2]. |
No Any Chemical & Physical Properties |